4basebio AG: 4basebio informs about takeover bid by Sparta AG
DGAP-News: 4basebio AG
/ Key word(s): Offer
According to Sparta AG, the final terms of conditions will be provided with a complete offer document to be found online at https://sparta.de/spv2/investoren/4basebio.
As required by German takeover law, the management board and supervisory board of 4basebio will submit a statement on the offer after publication of the offer document, to be published on www.investors.4basebio.com.
About 4base bio:
For further information, please contact:
MC Services AG (Investor Relations and International Media Relations)
### This publication is intended for information only and constitutes neither an offer to sell nor an invitation to buy securities. Some statements included in this press release, relating neither to proven financial results nor other historical data, should be viewed as forward-looking, i.e. not definite. Such statements are mainly predictions of future results, trends, plans or goals. These statements should not be considered to be total guarantees since given their very nature they are subject to known and unknown risks and imponderability and can be affected by other factors as a consequence of which the actual results, plans and goals of 4basebio AG may deviate greatly from the established conclusions or implied predictions contained in such statements. 4basebio does not undertake to publicly update or revise these statements in the light of new information or future results or for any other reason. ###
28.07.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
|Waldhofer Str. 102|
|Phone:||+49 (0) 6221 3540 125|
|Fax:||+49 (0) 6221 3540 127|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||1103245|
|End of News||DGAP News Service|